Cite
MLA Citation
F Ang et al.. “Effects of canagliflozin on cardiovascular and kidney outcomes and mortality in primary and secondary cardiovascular prevention: pooled analysis from the CANVAS program and CREDENCE trial.” European heart journal, vol. 43, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100168331148.0x000035